Posts Tagged: "ipwatchdog"

This week on IPWatchdog Unleashed, I sat down with my business and life partner, Renee Quinn. In addition to telling Renee’s story about how she found her way into the intellectual property world, and through our sometimes-comical banter, we together explore what it really takes to build, sustain, and continuously reinvent an entrepreneurial company like IPWatchdog. What emerged was a practical roadmap for entrepreneurship, invention, navigating platform risk, and focused on the necessity of constantly being ready to pivot as old business models start to show signs of age and ultimately falter. From Renee’s journey from IP outsider to patented inventor, to firsthand lessons learned navigating Amazon’s reseller ecosystem, the discussion highlights how intellectual property operates in the real world, not the classroom.

As we wind down 2025 it is time to reflect on the year that was, and what the future will bring. This year was punctuated by a structural reset for the U.S. patent system. What unfolded was not just incremental reform, but a coordinated shift driven by leadership change, policy realignment, economic pressure, and accelerating adoption of AI—all converging to reshape how patents are examined, challenged, monetized, and managed. This week on IPWatchdog Unleashed we explore the monumental changes and the biggest trends that impacted the patent and innovation industry during 2025, and which will play an important role in defining 2026.

There’s a lot going on at the Patent Trial and Appeal Board (PTAB) right now, and it’s not just the usual noise about discretionary denial. The United States Patent and Trademark Office (USPTO) has published a one-and-done rules package that, if it survives, would fundamentally change how inter partes review (IPR) challenge works, who can challenge patents, and when. The comment window on the proposed one-and-done rule has now closed. With more than 10,000 comments received by the USPTO and over 700 individual commenters weighing in, the proposed rules package has become a flashpoint for questions that go way beyond discretionary denial and AIA trials, with many asking whether the USPTO is functionally trying to engage in de facto legislation to neuter the PTAB.

This week on IPWatchdog Unleashed, I was joined by my longtime friend John White, who is the the creator of the patent bar review course I’ve taught for almost 27 years. Together we explore the intricate and ever changing patent landscape. First, we begin by discussing the bar exam and how it is changing, then we pivot to the evolving role of AI in patent law more generally. Our conversation traversed decades of personal history, friendship and professional insights, revealing how the industry has transformed over the years and what it means for the current and future generation of patent practitioners.

This week on IPWatchdog Unleashed, we feature a panel discussion that took place on October 27 as a part of our annual life sciences program. Initially styled as a conversation about how artificial intelligence is transforming life sciences, it became quickly apparent that the conversation was not going to be limited to the life sciences sector. Instead the discussion evolved into a robust discussion about data risk and intellectual property, focusing on what every innovative company should have front of mind when considering the adoption of AI tools.

In our latest IPWatchdog Unleashed podcast, I spoke with Rob Sahr, shareholder at Wolf Greenfield and co-chair of our 2025 Life Sciences Masters™ program. Our conversation zeroed in on a hard truth the public rarely sees: moving a molecule from early discovery to an FDA-approved therapy requires a chain of scientific and economic miracles—and every one of them leans on a reliable patent system. In this conversation we discuss the extraordinary journey from molecule to medicine. Together, we explore how scientific breakthroughs depend not only on research and capital, but also on a stable and predictable patent system. From double patenting and government funding to judicial uncertainty and policy headwinds, our conversation dives into the fragile balance between innovation and patent policy—and the many scientific miracles required to bring new drugs to life.

In our latest IPWatchdog Unleashed podcast, we had a riveting and sometimes emotional conversation that unfolded around one of the most pressing issues in life sciences today: the journey of life-saving drugs from laboratory to patient. We discuss the pivotal role a strong patent system plays in this important journey with guest Sherry Knowles. Sherry is the founder of Knowles Intellectual Property Strategies and former Senior Vice President and Chief Patent Counsel for GlaxoSmithKline. In addition to being one of the leading voices in the life sciences and patent industries, Sherry is also a cancer survivor. Among other things we discuss numerous patent system challenges facing innovator drug companies, the downward pressure generic drugs place on the industry and leading to important drugs becoming unavailable, the role of Pharmacy Benefit Managers (PBMs) with respect to significantly raising the cost of drugs for Americans, and policy influences and legislation on Capitol Hill. Sherry also shares her personal story and insights into why patents are more than just legal constructs—they are deeply personal lifelines.

This week on IPWatchdog Unleashed we tackle the impact of tariffs and geopolitical uncertainty on intellectual property (IP) strategy, budgets and patent portfolios.  In today’s fast-paced global economy, intellectual property (IP) teams face unprecedented challenges and opportunities. The world is witnessing a flux of geopolitical tensions, economic uncertainties, and rapid technological advancements, all of which demand agility and strategic foresight from IP professionals. Meanwhile, to complicate matters the United States is attempting to rearrange international business norms by diversifying supply chains for particularly important goods and components, while simultaneously aggressively using tariffs to change global economic behavior and settle international conflicts and wars. There is no doubt that this is a tumultuous time for all businesses, which demands attention, forethought and deliberate strategic action.

This week on IPWatchdog Unleashed we tackle the impact of tariffs and geopolitical uncertainty on intellectual property (IP) strategy, budgets and patent portfolios.  In today’s fast-paced global economy, intellectual property (IP) teams face unprecedented challenges and opportunities. The world is witnessing a flux of geopolitical tensions, economic uncertainties, and rapid technological advancements, all of which demand agility and strategic foresight from IP professionals. Meanwhile, to complicate matters the United States is attempting to rearrange international business norms by diversifying supply chains for particularly important goods and components, while simultaneously aggressively using tariffs to change global economic behavior and settle international conflicts and wars. There is no doubt that this is a tumultuous time for all businesses, which demands attention, forethought and deliberate strategic action.

On Friday, October 10, we hosted an impromptu webinar with the intention of using that conversation as our next podcast. While this is not always feasible, because we do often have PowerPoint slides when we host webinars, this webinar was simply a conversation about a very important recent decision of the Unified Patent Court (UPC) without any slides. The case we discuss is Philips v. Belkin, where after the conclusion of all appeals, the UPC issued the first ever final permanent injunction in a case involving standard essential patents (SEPs). So, our conversation this week is about the impact and ramifications of the UPC’s final decision in Philips v. Belkin. We discussed the UPC’s final decision and permanent injunction in Philips v. Belkin with an in-house attorney from Philips and the litigation team at Bardehle Pagenberg in Germany that represented Philips in this important win. By originally having this conversation as a webinar with a live audience, I was able to incorporate questions from the audience, which you’ll hear periodically throughout the podcast.

This week on IPWatchdog Unleashed, I speak with Dana Colarulli, who is a partner at ACG Advocacy—one of the premiere intellectual property lobby firms in Washington, DC. During our conversation we delve into the intricate world of patent policy and politics, discussing laws, the dynamic environment at the USPTO. Dana shares his extensive experience and insights on high-growth technology businesses. We address critical topics such as the recent shake-ups at the USPTO, the controversial “patent tax” proposal, how despite the fact that the USPTO is user-fee funded it is being swept up in broader Trump Administration efforts to downsize the federal government, what the word “innovation” really means, how businesses use intellectual property assets, the importance of predictable IP assets, the challenges of effective patent valuation, international collaboration and education to support small and medium size enterprises (SMEs), and much more.

This week on IPWatchdog Unleashed, we welcome Marlene Valderrama, who is Principal Intellectual Property Manager & Technology Scout for Halliburton. During our conversation, Marlene shares insights from her role as an innovation scout, the challenges of encouraging innovators inside Halliburton to recognize the importance and magnitude of their novel contributions, and the exciting advancements in drilling technology facilitated by AI. The conversation delves into best practices for AI implementation and the importance of continuous training for IP and innovation management. Additionally, Marlene opens up about her personal journey, her unexpected career path from drilling engineer to IP advocate, her passion for giving back through long-distance biking to raise money for multiple sclerosis research, and much more.

In a spirited discussion at our annual Women’s IP Forum, attendees were treated to an insightful fireside-style chat conversation with the Honorable Judge Pauline Newman, a trailblazer for women in law and a luminary in the field of intellectual property. Judge Newman spoke with Renee C. Quinn, Chief Operating Officer of IPWatchdog, Inc. Her career has been marked by a commitment to innovation and the advancement of strong intellectual property rights, shaping the very foundation of modern patent law. But did you know that Judge Newman was until a few years ago an active and licensed pilot? Did you know that she tutored singer/ songwriter legend Joan Baez in chemistry when Baez was in high school? While so much of Judge Newman’s life has been well documented, there are so many layers to her extraordinary life.

This week on IPWatchdog Unleashed, I had the pleasure of speaking with Daren Tang, Director General of the World Intellectual Property Organization (WIPO). Our conversation spanned a range of topics, from the future of intellectual property (IP), to how intellectual property has been a force for helping humanity, to WIPO’s strategic initiatives and the burgeoning impact of artificial intelligence (AI). A central theme of our conversation was Tang’s fervent advocacy for intellectual property as a catalyst for global innovation and betterment of the human condition.